Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07307898

Cavitaion vs W-BEMS on Central Obesity

The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Central Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Abdominal Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Cairo, Qalyubia Governorate, 13611, Egypt

About this study

Sixty individuals with central obesity were recruited from private clinics. And underwent a screening process to determine their eligibility based on the inclusion and exclusion criteria. Eligible participants were informed about the study details, procedures, potential risks, and benefits before obtaining written informed consent

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-50 years.
  • Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women.
  • Participants with a stable body weight for at least three months prior to the study.
  • No engagement in regular physical activity or weight loss programs in the past six months.
  • Willingness to adhere to study protocols and attend all scheduled sessions.

Exclusion criteria

  • Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension.
  • Pregnant or lactating women.
  • Individuals with implanted electronic devices (e.g., pacemakers).
  • Participants with dermatological conditions or skin infections in the treatment area.
  • Individuals undergoing medication that may affect fat metabolism or inflammatory markers.

Treatment and study plan

cavitation, whole body electromyostimulation

Device

The duration of the study was set for 12 weeks. Assessments were meticulously conducted at both the baseline and the conclusion of the study period to evaluate outcomes across the different groups.

Primary outcomes

  1. Inflammatory Markers

    Time frame: 3 Monthes

    Measurement of changes in levels of Tumor Necrosis Factor-alpha (TNF-alpha), and Interleukin-6 (IL-6) using ELISA (Enzyme-Linked Immunosorbent Assay) kits.

Secondary outcomes

  1. Waist Circumference

    Time frame: 3 Monthes

    Will be measured at the level of the iliac crest using a standard measuring tape to assess changes in central adiposity.

  2. Body Weight

    Time frame: 3 Monthes

    Standard clinical scales to measure body weight at each visit to track changes over the study period.

  3. Body Mass Index (BMI)

    Time frame: 3 Monthes

    Will be calculated using measured height and weight (kg/m²) to observe changes in overall body mass classification.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Cavitation Versus Whole-Body Electromyostimulation on Infilamatory Markers in Centeral Obesity

Acronym: w-bems

Important dates

Study start
2024
Primary completion
2024
Study completion
2026
First posted
Dec 29, 2025
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.